SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,549,000 | +60.1% | 450,000 | +51.3% | 2.20% | +84.6% |
| Q2 2023 | $34,069,700 | -40.6% | 297,500 | -28.5% | 1.19% | -37.5% |
| Q1 2023 | $57,337,280 | -58.1% | 416,000 | -60.6% | 1.90% | -35.8% |
| Q4 2022 | $136,706,900 | +30.4% | 1,055,000 | +11.3% | 2.96% | +39.0% |
| Q3 2022 | $104,814,000 | +182.8% | 948,200 | +336.2% | 2.13% | +77.1% |
| Q4 2020 | $37,065,000 | +373.6% | 217,400 | +171.8% | 1.20% | +11.2% |
| Q1 2020 | $7,826,000 | – | 80,000 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |